COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out and merger planned
APONTIS PHARMA reports significant sales and earnings increase in 2024 financial year, plans squeeze-out and merger with Zentiva AG. EBITDA rises to EUR 3.5 million from previous year's EUR -13.3 million -
-
-
COMMUNIQUÉ DE PRESSE
EV Nickel Drills Best Hole to Date & Expands Nickel Sulphide Zone at Gemini North Intersecting 186.5m Grading 0.36% Nickel
EV Nickel Inc. announces successful results from diamond drill program at the Gemini North Zone on Shaw Dome Project. The program reveals high-grade nickel mineralization, enrichened sulphur contents, and potential for a magmatic sulphide source -
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the minority shareholders of APONTIS PHARMA AG – merger agreement planned
Zentiva AG submits formal request for merger squeeze-out of minority shareholders of APONTIS PHARMA AG. Merger agreement planned as majority shareholder Zentiva holds 93.83% of share capital
